SCHEMBL8631445

SCHEMBL8631445

CN(CCCNCCCCCCCCNCCCN)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.50
▸ CHRM2 P08172 1/20 0.42
▸ CA12 O43570 2/20 0.42
▸ F13A1 P00488 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ CA4 P22748 2/20 0.42
▸ CA6 P23280 2/20 0.42
▸ CA5A P35218 2/20 0.42
▸ THPO P40225 2/20 0.42
▸ CA7 P43166 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ CA14 Q9ULX7 2/20 0.42
▸ CA5B Q9Y2D0 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CASP2 P42575 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8642021 0.98 TDP1 (0.49) TDP1CHRM2CA12F13A1CA2
SCHEMBL8643584 0.94 CHRM2 (0.46) TDP1CHRM2CA12F13A1CA2
Hydrochloric Acid SCHEMBL8647546 0.92 CHRM2 (0.44) TDP1CHRM2
SCHEMBL8642725 0.89 CYP2C9 (0.46) CHRM2CYP2C19CYP2C9
SCHEMBL8032634 0.85 MEN1 (0.46) CHRM2MEN1KMT2AHSD17B10BCHE
SCHEMBL7986744 0.84 MEN1 (0.45) CHRM2MEN1KMT2AHSD17B10BCHE
SCHEMBL8030791 0.84 MEN1 (0.45) CHRM2MEN1KMT2AHSD17B10BCHE
SCHEMBL8034855 0.84 MEN1 (0.45) CHRM2MEN1KMT2AHSD17B10BCHE
SCHEMBL8030659 0.84 ALDH1A1 (0.47) CHRM2MEN1KMT2AHSD17B10BCHE
SCHEMBL8029013 0.84 ALDH1A1 (0.47) CHRM2MEN1KMT2AHSD17B10BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5719193-A Method of potentiating cell-mediated immunity utilizing polyamine derivatives MERRELL PHARMACEUTICALS, INC. (US) 1998-02-17 — — US claimed
US-5753714-A ANTIPROTOZOA AGENTS MERRELL PHARMACEUTICALS INC. (US) 1998-05-19 — — US disclosed
US-5719193-A Method of potentiating cell-mediated immunity utilizing polyamine derivatives MERRELL PHARMACEUTICALS, INC. (US) 1998-02-17 — — US disclosed
EP-0277635-A2 Novel polyamine derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1988-08-10 — — EP disclosed
Send feedback